These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


151 related items for PubMed ID: 15354876

  • 1. [In spite of lacking abdominal complaints. Intestinal disease was diagnosed because of the lips].
    Stiefelhagen P.
    MMW Fortschr Med; 2004 Jun 17; 146(25):10. PubMed ID: 15354876
    [No Abstract] [Full Text] [Related]

  • 2. [Acute episode].
    Schölmerich J, German Society for Digestive and Metabolic Diseases.
    Z Gastroenterol; 2003 Jan 17; 41(1):27-30. PubMed ID: 12541170
    [No Abstract] [Full Text] [Related]

  • 3. [New research results give hope. Causal therapy of Crohn disease in sight].
    MMW Fortschr Med; 2004 Apr 01; 146(14):42-3. PubMed ID: 15344754
    [No Abstract] [Full Text] [Related]

  • 4. [Maintaining a remission].
    Fleig WE, German Society for Digestive and Metabolic Diseases.
    Z Gastroenterol; 2003 Jan 01; 41(1):36-42. PubMed ID: 12541172
    [No Abstract] [Full Text] [Related]

  • 5. [Paradigmatic shift in drug treatment of Crohn disease].
    Munck LK.
    Ugeskr Laeger; 2005 Aug 15; 167(33):3013. PubMed ID: 16109239
    [No Abstract] [Full Text] [Related]

  • 6. [Chronic inflammatory bowel diseases. Update on evidence-based therapy].
    MMW Fortschr Med; 2005 Apr 28; 147(17):58-9. PubMed ID: 15903063
    [No Abstract] [Full Text] [Related]

  • 7. [Mesalazine is without clinical effect in patients with Crohn disease].
    Munck LK.
    Ugeskr Laeger; 2005 Jan 17; 167(3):302-3. PubMed ID: 15704804
    [No Abstract] [Full Text] [Related]

  • 8. You're the flight surgeon. Crohn's disease.
    Hartwich SA.
    Aviat Space Environ Med; 2004 Aug 17; 75(8):716-7. PubMed ID: 15328792
    [No Abstract] [Full Text] [Related]

  • 9. [For treatment decision the age to be taken into account. In Crohn's disease and ulcerative colitis attention to be paid to the age at manifestation].
    MMW Fortschr Med; 2009 May 07; 151(19):38-9. PubMed ID: 19827443
    [No Abstract] [Full Text] [Related]

  • 10. [Crohn's disease and tobacco consumption].
    Weber P, Zimmer KP.
    Dtsch Med Wochenschr; 1995 Sep 15; 120(37):1261-2. PubMed ID: 7671789
    [No Abstract] [Full Text] [Related]

  • 11. Cheilitis granulomatosa.
    van der Waal RI, Schulten EA, van de Scheur MR, Wauters IM, Starink TM, van der Waal I.
    J Eur Acad Dermatol Venereol; 2001 Nov 15; 15(6):519-23. PubMed ID: 11843210
    [Abstract] [Full Text] [Related]

  • 12. Can postoperative relapse of Crohn's disease be prevented?
    Dumois RA, Herrera JL.
    Am J Gastroenterol; 2001 Jan 15; 96(1):249. PubMed ID: 11197264
    [No Abstract] [Full Text] [Related]

  • 13. Inflammatory pseudotumor of the liver as the first manifestation of Crohn's disease.
    Amankonah TD, Strom CB, Vierling JM, Petrovic LM.
    Am J Gastroenterol; 2001 Aug 15; 96(8):2520-2. PubMed ID: 11513216
    [No Abstract] [Full Text] [Related]

  • 14. [New therapeutic modalities in Crohn's disease].
    Rachmilewitz D.
    Harefuah; 1999 Jun 15; 136(12):943-5. PubMed ID: 10955155
    [No Abstract] [Full Text] [Related]

  • 15. [Mesalamine in the treatment of Crohn disease?].
    Nielsen OH, Thomsen OO.
    Ugeskr Laeger; 2005 Apr 11; 167(15):1656-7. PubMed ID: 15892345
    [No Abstract] [Full Text] [Related]

  • 16. [Crohn's disease surgery: problems of postoperative recurrence].
    Fornaro R, Frascio M, Stabilini C, Sticchi C, Barberis A, Denegri A, Ricci B, Azzinnaro A, Lazzara F, Gianetta E.
    Chir Ital; 2008 Apr 11; 60(6):761-81. PubMed ID: 19256268
    [Abstract] [Full Text] [Related]

  • 17. [Crohn disease].
    Kolyvanos Naumann U, Kaser L, Vetter W.
    Praxis (Bern 1994); 2003 May 14; 92(20):933-5. PubMed ID: 14565224
    [No Abstract] [Full Text] [Related]

  • 18. [Mesalazine is effective in Crohn disease].
    Quartarolo JP.
    Ugeskr Laeger; 2005 Apr 18; 167(16):1767. PubMed ID: 15898611
    [No Abstract] [Full Text] [Related]

  • 19. Severe exudative ascites as an initial presentation of Crohn's disease.
    Tekin F, Vatansever S, Ozütemiz O, Musoğlu A, Ilter T.
    Turk J Gastroenterol; 2005 Sep 18; 16(3):171-3. PubMed ID: 16245232
    [Abstract] [Full Text] [Related]

  • 20. [Mesalazine is effective in Crohn disease 2].
    Quartarolo JP, Laegemidler F, Eskerod O.
    Ugeskr Laeger; 2005 Mar 14; 167(11):1308-9; author reply 1309. PubMed ID: 15830510
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.